The majority of molecular diagnostics systems available on the market today are extremely complex and require considerable hands-on time in addition to highly qualified laboratory personnel. As such, their availability for use is very limited to central laboratories and specialist laboratories.
With the Unyvero solution, Curetis has introduced a brand-new molecular diagnostics system to the market. This new system enables reliable and extremely rapid diagnosis of severe infectious diseases within just four to five hours. The system tests a wide variety of pathogens and antibiotic resistance markers simultaneously.
Curetis Unyvero HPN Application Receives Singapore Health Sciences Authority Approval; Updates on Sepsis Host Response Test
Curetis Group: Ares Genetics Receives Funding Commitment For EUR 1.6 Mio. Project; Curetis Announces Non-Audited Financial Results for 2017
28. Symposium Intensivmedizin + Intensivpflege - Bremen, Germany - 14 to 16 February, 2018
70th Annual Meeting of the German Society for Hygiene and Microbiology (DGHM), Bochum, Germany - February 19 to 21, 2018